Stock AKBA AKEBIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq
Other stock markets
 01:30:00 16/05/2024 am IST 		5-day change 1st Jan Change
1.18 USD -4.07% Intraday chart for Akebia Therapeutics, Inc. -15.71% -4.84%
09/05 Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
09/05 Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKEBIA THERAPEUTICS, INC. Stock Akebia Therapeutics, Inc.
 247M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 113B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 22.27B -
BIONTECH SE Stock BioNTech SE
 22.22B -
GENMAB A/S Stock Genmab A/S
 19.43B
  1. Stock Market
  2. Equities
  3. AKBA Stock
  4. Charts Akebia Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW